Simultaneous osteonecrosis and osteomyelitis in a patient with cancer of the breast

K. Y. Huang, R. S. Yang, C. C. Hsieh

研究成果: Article同行評審

摘要

Breast cancer is generally managed surgically with adjuvant agents which include hormone therapy, chemotherapy, radiotherapy and bisphosphonate therapy. However, some of these adjuvant therapies may cause adverse events, including wound infection, neutropenia, bone marrow suppression and fever. The simultaneous presentation of osteonecrosis and osteomyelitis has not previously been described in patients with breast cancer undergoing hormone therapy and chemotherapy. We report a patient with breast cancer who developed bone infarcts in both legs as well as osteomyelitis in the right distal tibia after treatment which included a modified radical mastectomy, hormone therapy and chemotherapy. Simultaneous osteonecrosis and osteomyelitis should be considered in patients with breast cancer who are receiving chemotherapy and hormone therapy who present with severe bone pain, especially if there have been infective episodes during treatment.

原文English
頁(從 - 到)1249-1251
頁數3
期刊Journal of Bone and Joint Surgery - Series B
91
發行號9
DOIs
出版狀態Published - 2009 九月

All Science Journal Classification (ASJC) codes

  • 手術
  • 骨科和運動醫學

指紋

深入研究「Simultaneous osteonecrosis and osteomyelitis in a patient with cancer of the breast」主題。共同形成了獨特的指紋。

引用此